CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
出版年份 2019 全文链接
标题
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-27
DOI
10.3389/fimmu.2019.02310
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
- (2019) Yonatan Ganor et al. Nature Microbiology
- Urethral macrophages — a new HIV-1 reservoir
- (2019) Conor A. Bradley Nature Reviews Urology
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- Antibody-induced internalization of HIV-1 Env proteins limits the surface expression of the closed conformation of Env
- (2019) Sai Priya Anand et al. JOURNAL OF VIROLOGY
- CRISPR-Based Tools in Immunity
- (2019) Dimitre R. Simeonov et al. Annual Review of Immunology
- Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
- (2019) Chang-Yi Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV
- (2018) Emmanouil Papasavvas et al. AIDS
- Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
- (2018) Vanessa A. Evans et al. AIDS
- Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with minimal immunogenicity
- (2018) Mustafa H. Ghanem et al. CYTOTHERAPY
- STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
- (2018) Yu-Lin Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HIV-1 latent reservoir size and diversity are stable following brief treatment interruption
- (2018) D. Brenda Salantes et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential Expression of CD8+T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection
- (2018) Brenna E. Kiniry et al. JOURNAL OF IMMUNOLOGY
- Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA
- (2018) Zachary Strongin et al. JOURNAL OF VIROLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
- (2018) Mohamed Abdel-Mohsen et al. Science Translational Medicine
- CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
- (2018) Roger Badia et al. Nature Communications
- HIV integration sites and implications for maintenance of the reservoir
- (2018) Jori Symons et al. Current Opinion in HIV and AIDS
- Lessons learned from HIV antiretroviral treatment interruption trials
- (2018) Ying Wen et al. Current Opinion in HIV and AIDS
- Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium
- (2018) Andrew R. Medvec et al. Molecular Therapy-Methods & Clinical Development
- The Pharmacology of T Cell Therapies
- (2018) Michael C. Milone et al. Molecular Therapy-Methods & Clinical Development
- Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition
- (2018) Christopher Ecker et al. Cell Metabolism
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Emerging Cellular Therapies for Cancer
- (2018) Sonia Guedan et al. Annual Review of Immunology
- Acquired mechanisms of immune escape in cancer following immunotherapy
- (2018) J. Bryan Iorgulescu et al. Genome Medicine
- Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
- (2017) Malika Hale et al. MOLECULAR THERAPY
- Defining total-body AIDS-virus burden with implications for curative strategies
- (2017) Jacob D Estes et al. NATURE MEDICINE
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A versatile system for rapid multiplex genome-edited CAR T cell generation
- (2017) Jiangtao Ren et al. Oncotarget
- HIV-Specific CD8 + T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue
- (2017) Morgan A. Reuter et al. Cell Reports
- Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor
- (2017) Rachel S. Leibman et al. PLoS Pathogens
- Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis
- (2016) S Teeraananchai et al. HIV MEDICINE
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
- (2016) Marco Ruella et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies
- (2016) Ayub Ali et al. JOURNAL OF VIROLOGY
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
- (2016) Riddhima Banga et al. NATURE MEDICINE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
- (2016) Glen M. Chew et al. PLoS Pathogens
- Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
- (2016) Matthias Hoffmann et al. PLoS Pathogens
- ADDENDUM: T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
- Targeting the Brain Reservoirs: Toward an HIV Cure
- (2016) Céline Marban et al. Frontiers in Immunology
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- The Upregulation of LAG-3 on T Cells Defines a Subpopulation with Functional Exhaustion and Correlates with Disease Progression in HIV-Infected Subjects
- (2015) Xiaoling Tian et al. JOURNAL OF IMMUNOLOGY
- Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity
- (2015) Li Liu et al. JOURNAL OF VIROLOGY
- HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells
- (2015) Anjie Zhen et al. MOLECULAR THERAPY
- Engineering T Cells to Functionally Cure HIV-1 Infection
- (2015) Rachel S Leibman et al. MOLECULAR THERAPY
- B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
- (2015) Yoshinori Fukazawa et al. NATURE MEDICINE
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Toward Synthetic Biology with Engineered T Cells: A Long Journey Just Begun
- (2014) Carl H. June HUMAN GENE THERAPY
- Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection
- (2014) V. Cecchinato et al. JOURNAL OF IMMUNOLOGY
- Expansion of Dysfunctional Tim-3–Expressing Effector Memory CD8+T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
- (2014) Tsuyoshi Fujita et al. JOURNAL OF IMMUNOLOGY
- A novel real-time CTL assay to measure designer T-cell function against HIV Env+cells
- (2014) Andrew G. MacLean et al. JOURNAL OF MEDICAL PRIMATOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5
- (2013) Dawn A. Maier et al. HUMAN GENE THERAPY
- Macrophages Accumulate in the Gut Mucosa of Untreated HIV-infected Patients
- (2013) K. Allers et al. JOURNAL OF INFECTIOUS DISEASES
- Combination Checkpoint Blockade — Taking Melanoma Immunotherapy to the Next Level
- (2013) James L. Riley NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Novel Cell and Gene Therapies for HIV
- (2013) J. A. Hoxie et al. Cold Spring Harbor Perspectives in Medicine
- Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
- (2012) Hans-Peter Kiem et al. Cell Stem Cell
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production
- (2012) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression
- (2011) A. R. Hersperger et al. BLOOD
- One Protein to Rule them All: Modulation of Cell Surface Receptors and Molecules by HIV Nef
- (2011) Alessia Landi et al. CURRENT HIV RESEARCH
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
- (2011) Claudia Cicala et al. Journal of Translational Medicine
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control
- (2010) Adam R. Hersperger et al. PLoS Pathogens
- Redefining Chronic Viral Infection
- (2009) Herbert W. Virgin et al. CELL
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells
- (2009) Gary P Wang et al. MOLECULAR THERAPY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
- (2008) Stephen A. Migueles et al. IMMUNITY
- The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression
- (2008) P. K. Chattopadhyay et al. JOURNAL OF LEUKOCYTE BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started